Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 5, Number 1—February 1999

Synopsis

Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases

Larry Zeitlin*, Richard A. Cone*†, and Kevin J. Whaley*†Comments to Author 
Author affiliations: *ReProtect, LLC, Baltimore, Maryland, USA; †The Johns Hopkins University, Baltimore, Maryland, USA

Main Article

Table 3

Preventive vaccines or cures for major sexually transmitted disease pathogens

Pathogen Vaccine Cure DRSa
Chlamydia trachomatis no yes
Haemophilus ducreyi no yes X
Hepatitis B yes no
Herpes simplex 1 and 2 no no X
HIV-1 and 2 no no X
Human papilloma virus (HPV) no yesb
Neisseria gonorrhoeae no yes X
Treponema pallidum no yes
Trichomonas vaginalis no yes X

aDrug-resistant strains reported.
bSurgical removal of HPV-infected tissue is performed.HPV-related cervical cancer identified early has a high cure rate; however, in the United States, for every three new cases, there is approximately one death (117).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO